Estimating Normal Reference Interval for Soluble B-Cell Maturation Antigen Levels in Adults: A Prospective Study from a Tertiary Care Center in Southern India
- 8 September 2025
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 42 (4) , 1366-1373
Abstract
Section Purpose of the Study This study aimed to estimate the reference interval for soluble B cell maturation antigen (sBCMA) in adults from Southern India. AbstractSection Methods A total of 84 participants were enrolled. The sBCMA levels were measured, and statistical analyses were performed to assess differences across gender, age, and the presence of comorbidities such as diabetes mellitus (DM), hypertension (HTN), dyslipidemia (DLP), and obesity. Reference intervals were determined using a nonparametric approach with 95% coverage. AbstractSection Results The median sBCMA level was 74 ng/ml, with a mean of 75.52 ± 12.99 ng/ml. No significant differences were observed in sBCMA levels across gender, age, or comorbidities (p > 0.05). The mean differences between subgroups were below 13 ng/ml (25% of 52 ng/ml), indicating that partitioning reference ranges by subgroups was not required. The suggested reference interval for sBCMA in the study population is 54.75–106.75 ng/ml at 95% coverage. The suggested reference interval for our population is notably higher than that reported for the Caucasian population. Multiple reasons can account for this difference, including ethnic and genetic variation, environmental exposure, nutritional factors, analytical variation, and population characteristics. AbstractSection Conclusion This study provides a population-specific reference interval for sBCMA in South Indian adults. Given the significant difference from Caucasian reference values, further research is needed to explore the underlying causes of this variation.Keywords
Funding Information
- Amrita Vishwa Vidyapeetham University (Amrita Vishwa Vidyapeetham University)
This publication has 34 references indexed in Scilit:
- Soluble B‐cell maturation antigen in multiple myelomaAmerican Journal of Hematology, 2024
- Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinentCytometry Part B: Clinical Cytometry, 2022
- Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple MyelomaTransplantation and Cellular Therapy, 2022
- Hematologic malignancies of primary bone marrow involvement: a decade's experience in BahrainHematology, Transfusion and Cell Therapy, 2022
- Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI TrialClinical Lymphoma Myeloma and Leukemia, 2021
- Multiple Myeloma in Young Adults: A Single Centre Real World ExperienceIndian Journal of Hematology and Blood Transfusion, 2021
- Plasma B-Cell Maturation Antigen Levels are Elevated and Correlate with Disease Activity in Patients with Chronic Lymphocytic LeukemiaTargeted Oncology, 2019
- Serum B-cell maturation antigen (BCMA) reduces binding of anti-BCMA antibody to multiple myeloma cellsLeukemia Research, 2019
- Distribution of multiple myeloma in India: Heterogeneity in incidence across age, sex and geographyCancer Epidemiology, 2019
- A new approach to sample size calculation for reference interval studiesStatistics in Medicine, 2005